Compagnie Lombard Odier SCmA’s Thermo Fisher Scientific TMO Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | $147M | Sell |
299,245
-410
| -0.1% | -$223K | 1.81% | 18 |
|
|
2025
Q4 | $174M | Buy |
299,655
+5,895
| +2% | +$3.33M | 1.89% | 14 |
|
|
2025
Q3 | $142M | Buy |
293,760
+13,032
| +5% | +$6.07M | 1.57% | 17 |
|
|
2025
Q2 | $114M | Buy |
280,728
+30,461
| +12% | +$12.7M | 1.5% | 17 |
|
|
2025
Q1 | $125M | Buy |
250,267
+56,371
| +29% | +$30.5M | 1.53% | 16 |
|
|
2024
Q4 | $101M | Sell |
193,896
-18,576
| -9% | -$10.2M | 1.49% | 15 |
|
|
2024
Q3 | $131M | Buy |
212,472
+14,226
| +7% | +$8.42M | 2.04% | 13 |
|
|
2024
Q2 | $110M | Sell |
198,246
-4,630
| -2% | -$2.65M | 1.85% | 15 |
|
|
2024
Q1 | $118M | Buy |
202,876
+8,155
| +4% | +$4.58M | 2.09% | 11 |
|
|
2023
Q4 | $103M | Sell |
194,721
-9,161
| -4% | -$4.43M | 1.92% | 12 |
|
|
2023
Q3 | $103M | Buy |
203,882
+14,221
| +7% | +$7.58M | 2.39% | 11 |
|
|
2023
Q2 | $99M | Sell |
189,661
-7,607
| -4% | -$4.1M | 2.77% | 9 |
|
|
2023
Q1 | $114M | Sell |
197,268
-20,613
| -9% | -$11.6M | 2.84% | 9 |
|
|
2022
Q4 | $120M | Buy |
217,881
+4,173
| +2% | +$2.21M | 3.21% | 8 |
|
|
2022
Q3 | $108M | Buy |
213,708
+1,778
| +0.8% | +$995K | 3.12% | 8 |
|
|
2022
Q2 | $115M | Sell |
211,930
-3,295
| -2% | -$1.81M | 2.92% | 8 |
|
|
2022
Q1 | $127M | Sell |
215,225
-18,724
| -8% | -$10.8M | 2.69% | 8 |
|
|
2021
Q4 | $156M | Sell |
233,949
-4,627
| -2% | -$2.89M | 3.09% | 6 |
|
|
2021
Q3 | $136M | Sell |
238,576
-23,290
| -9% | -$12.8M | 2.94% | 7 |
|
|
2021
Q2 | $132M | Buy |
261,866
+3,571
| +1% | +$1.68M | 2.9% | 7 |
|
|
2021
Q1 | $118M | Sell |
258,295
-4,195
| -2% | -$2M | 2.6% | 7 |
|
|
2020
Q4 | $122M | Buy |
262,490
+2,760
| +1% | +$1.29M | 3.15% | 9 |
|
|
2020
Q3 | $115M | Buy |
259,730
+1,340
| +0.5% | +$554K | 3.42% | 7 |
|
|
2020
Q2 | $93.6M | Buy |
258,390
+9,721
| +4% | +$3.26M | 3.14% | 8 |
|
|
2020
Q1 | $70.5M | Buy |
248,669
+19,311
| +8% | +$6.09M | 2.96% | 9 |
|
|
2019
Q4 | $74.5M | Sell |
229,358
-3,760
| -2% | -$1.14M | 2.85% | 10 |
|
|
2019
Q3 | $67.9M | Buy |
233,118
+42,276
| +22% | +$12.1M | 2.84% | 9 |
|
|
2019
Q2 | $56M | Sell |
190,842
-16,413
| -8% | -$4.52M | 2.27% | 12 |
|
|
2019
Q1 | $56.7M | Buy |
207,255
+75,131
| +57% | +$18.7M | 2.34% | 12 |
|
|
2018
Q4 | $29.6M | Buy |
132,124
+112,165
| +562% | +$26.3M | 1.21% | 25 |
|
|
2018
Q3 | $4.87M | Buy |
19,959
+4,894
| +32% | +$1.13M | 0.17% | 88 |
|
|
2018
Q2 | $3.12M | Buy |
15,065
+10,425
| +225% | +$2.21M | 0.11% | 118 |
|
|
2018
Q1 | $959K | Sell |
4,640
-10,784
| -70% | -$2.26M | 0.03% | 177 |
|
|
2017
Q4 | $2.93M | Buy |
15,424
+8,581
| +125% | +$1.64M | 0.05% | 159 |
|
|
2017
Q3 | $1.3M | Sell |
6,843
-350
| -5% | -$63.4K | 0.05% | 198 |
|
|
2017
Q2 | $1.25M | Sell |
7,193
-675
| -9% | -$113K | 0.04% | 202 |
|
|
2017
Q1 | $1.21M | Sell |
7,868
-2,135
| -21% | -$326K | 0.04% | 210 |
|
|
2016
Q4 | $1.41M | Sell |
10,003
-850
| -8% | -$125K | 0.04% | 219 |
|
|
2016
Q3 | $1.73M | Sell |
10,853
-350
| -3% | -$53.9K | 0.05% | 204 |
|
|
2016
Q2 | $1.66M | Sell |
11,203
-1,735
| -13% | -$256K | 0.05% | 212 |
|
|
2016
Q1 | $1.83M | Sell |
12,938
-1,740
| -12% | -$233K | 0.06% | 185 |
|
|
2015
Q4 | $2.08M | Buy |
14,678
+1,353
| +10% | +$180K | 0.07% | 160 |
|
|
2015
Q3 | $1.63M | Sell |
13,325
-3,600
| -21% | -$469K | 0.07% | 167 |
|
|
2015
Q2 | $2.19M | Sell |
16,925
-5,856
| -26% | -$763K | 0.08% | 159 |
|
|
2015
Q1 | $3.06M | Sell |
22,781
-85
| -0.4% | -$11K | 0.12% | 118 |
|
|
2014
Q4 | $2.87M | Sell |
22,866
-5,610
| -20% | -$682K | 0.13% | 101 |
|
|
2014
Q3 | $3.47M | Buy |
28,476
+16,779
| +143% | +$2.04M | 0.14% | 92 |
|
|
2014
Q2 | $1.38M | Buy |
11,697
+4,100
| +54% | +$483K | 0.05% | 154 |
|
|
2014
Q1 | $914K | Sell |
7,597
-1,599
| -17% | -$190K | 0.04% | 216 |
|
|
2013
Q4 | $1.02M | Buy |
+9,196
| New | +$914K | 0.04% | 204 |
|
Other funds holding TMO
VCM
Compagnie Lombard Odier SCmA's TMO Position: Q1 2026 in Review
Compagnie Lombard Odier SCmA reduced its Thermo Fisher Scientific (TMO) stake by 0.14% in Q1 2026, selling an estimated $223K and leaving 299,245 shares worth $147M. The position accounts for 1.81% of the portfolio, ranked #18.
Compagnie Lombard Odier SCmA first reported a position in TMO in Q4 2013 and has held it in 50 quarters since. The position peaked at $174M in Q4 2025. 2,588 funds tracked by Wall St. Rank hold TMO as of Q1 2026.
- Compagnie Lombard Odier SCmA held 299,245 shares of Thermo Fisher Scientific worth $147M as of Q1 2026.
- Compagnie Lombard Odier SCmA sold 410 Thermo Fisher Scientific shares in Q1 2026, an estimated $223K.
- Thermo Fisher Scientific made up 1.81% of Compagnie Lombard Odier SCmA's portfolio in Q1 2026, its #18 holding.
- Compagnie Lombard Odier SCmA first reported a position in Thermo Fisher Scientific in Q4 2013 and has held it in 50 quarters since.
- Compagnie Lombard Odier SCmA's Thermo Fisher Scientific position peaked at $174M in Q4 2025.
- 2,588 funds tracked by Wall St. Rank held Thermo Fisher Scientific as of Q1 2026.
Based on Compagnie Lombard Odier SCmA's 13F filing for Q1 2026, filed 15 Apr 2026.